Strs Ohio Trims Stake in Encompass Health Corporation $EHC

Strs Ohio reduced its stake in Encompass Health Corporation (NYSE:EHC) by 24.1% during the third quarter, Holdings Channel.com reports. The firm owned 243,286 shares of the company’s stock after selling 77,307 shares during the quarter. Strs Ohio’s holdings in Encompass Health were worth $30,902,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Tectonic Advisors LLC lifted its position in shares of Encompass Health by 1.6% during the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares in the last quarter. Global Retirement Partners LLC boosted its position in shares of Encompass Health by 23.0% in the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock worth $57,000 after purchasing an additional 84 shares during the period. EP Wealth Advisors LLC raised its position in shares of Encompass Health by 2.4% during the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the period. Natural Investments LLC lifted its stake in shares of Encompass Health by 1.2% during the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after buying an additional 89 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in Encompass Health by 1.1% in the 3rd quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock worth $1,044,000 after buying an additional 91 shares during the period. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on EHC shares. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. UBS Group increased their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Barclays lifted their price objective on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Finally, Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $142.86.

Encompass Health Stock Down 1.0%

Shares of EHC opened at $98.36 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.76. The business has a fifty day moving average of $107.79 and a 200 day moving average of $115.62. The company has a market cap of $9.90 billion, a PE ratio of 18.59, a P/E/G ratio of 1.60 and a beta of 0.74. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.04. The business had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The business’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 earnings per share. On average, sell-side analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.